logo
Select company
Select metric
$ -14.09MEarning Before Interest & Taxes (EBIT)
VS
Market
27
Sector
59
Industry
73
History
-
$ 3.31Close
$ 3.31 - $ 570.6 52-Week Range
Ticker Information

Ticker

CERO

Company Name

CERO THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERO THERAPEUTICS HOLDINGS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CERO - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -14.09M
3/31/2025$ -11.13M
12/31/2024$ -7.73M
12/31/2023$ -2.44M
9/30/2023$ -1.91M
6/30/2023$ -1.45M
3/31/2023$ -172.29K
12/31/2022$ -68.58K
6/30/2022$ -820.98K
12/31/2021$ -332.42K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERO THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) EBIT stands at $ -332.42K.
  • Over the past 5 years, CERO THERAPEUTICS HOLDINGS INC's average EBIT has been $ -4.02M.
  • The median EBIT for CERO THERAPEUTICS HOLDINGS INC during this period was $ -1.68M
  • CERO THERAPEUTICS HOLDINGS INC reached its highest EBIT over the past 5 years at $ -68.58K.
  • The lowest EBIT recorded by CERO THERAPEUTICS HOLDINGS INC in the same timeframe $ -14.09M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

CERO - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -14.09M

Minimum

Jun 30, 2025

$ -68.58K

Maximum

Dec 31, 2022

$ -4.02M

Average

$ -1.68M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.81M with a standard deviation of $ 130.86M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 443M
average$ 28.81M
median$ 1.05M
std$ 130.86M